206 related articles for article (PubMed ID: 26253281)
1. Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic Surgery.
Oduyebo T; Hinchcliff E; Meserve EE; Seidman MA; Quade BJ; Rauh-Hain JA; George S; Nucci MR; del Carmen MG; Muto MG
J Minim Invasive Gynecol; 2016 Jan; 23(1):34-9. PubMed ID: 26253281
[TBL] [Abstract][Full Text] [Related]
2. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.
George S; Barysauskas C; Serrano C; Oduyebo T; Rauh-Hain JA; Del Carmen MG; Demetri GD; Muto MG
Cancer; 2014 Oct; 120(20):3154-8. PubMed ID: 24923260
[TBL] [Abstract][Full Text] [Related]
3. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
4. Characterization and Preoperative Risk Analysis of Leiomyosarcomas at a High-Volume Tertiary Care Center.
Peters A; Sadecky AM; Winger DG; Guido RS; Lee TTM; Mansuria SM; Donnellan NM
Int J Gynecol Cancer; 2017 Jul; 27(6):1183-1190. PubMed ID: 28463949
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Malignancy and Myoma Variants at Surgery for Presumed Benign Symptomatic Myomas.
Damasco MR; Chan PK; Slonim M; Ang WC; Healey MG
J Minim Invasive Gynecol; 2017; 24(4):659-664. PubMed ID: 28216458
[TBL] [Abstract][Full Text] [Related]
6. Unexpected Uterine Leiomyosarcoma During Laparoscopic Hysterectomy Treated 6 Months With Ulipristal Acetate and Contained Power Morcellation.
Istre O
J Minim Invasive Gynecol; 2017 Feb; 24(2):198. PubMed ID: 27539216
[TBL] [Abstract][Full Text] [Related]
7. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
[TBL] [Abstract][Full Text] [Related]
8. Occult Leiomyosarcomas in a Canadian Province: A Retrospective Cohort Study.
Wu CQ; Woo LY; Giede KC; Thiel J; Karreman E; Rattray DD
J Obstet Gynaecol Can; 2019 Jan; 41(1):46-51. PubMed ID: 30341020
[TBL] [Abstract][Full Text] [Related]
9. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
Oduyebo T; Rauh-Hain AJ; Meserve EE; Seidman MA; Hinchcliff E; George S; Quade B; Nucci MR; Del Carmen MG; Muto MG
Gynecol Oncol; 2014 Feb; 132(2):360-5. PubMed ID: 24296345
[TBL] [Abstract][Full Text] [Related]
10. Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation.
Raine-Bennett T; Tucker LY; Zaritsky E; Littell RD; Palen T; Neugebauer R; Axtell A; Schultze PM; Kronbach DW; Embry-Schubert J; Sundang A; Bischoff K; Compton-Phillips AL; Lentz SE
Obstet Gynecol; 2016 Jan; 127(1):29-39. PubMed ID: 26646120
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
[TBL] [Abstract][Full Text] [Related]
12. Occult uterine leiomyosarcoma in women undergoing abdominal and minimally invasive surgeries for myomas.
Ludwin A; Gawron I; Pityński K
Ginekol Pol; 2018; 89(10):546-552. PubMed ID: 30393842
[TBL] [Abstract][Full Text] [Related]
13. Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations.
Sizzi O; Manganaro L; Rossetti A; Saldari M; Florio G; Loddo A; Zurawin R; van Herendael B; Djokovic D
Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():30-38. PubMed ID: 29149644
[TBL] [Abstract][Full Text] [Related]
14. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience.
Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS
J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821
[TBL] [Abstract][Full Text] [Related]
15. Feasibility, Safety, and Prediction of Complications for Minimally Invasive Myomectomy in Women With Large and Numerous Myomata.
Vargas MV; Moawad GN; Sievers C; Opoku-Anane J; Marfori CQ; Tyan P; Robinson JK
J Minim Invasive Gynecol; 2017 Feb; 24(2):315-322. PubMed ID: 27939896
[TBL] [Abstract][Full Text] [Related]
16. Unsuspected Uterine Sarcoma in an Urban Hospital: Does Surgical Approach Matter?
DiNapoli MN; Truong MD; Halfon JK; Burke WM
J Minim Invasive Gynecol; 2018; 25(3):491-497. PubMed ID: 29061369
[TBL] [Abstract][Full Text] [Related]
17. Electric morcellation-related reoperations after laparoscopic myomectomy and nonmyomectomy procedures.
Pereira N; Buchanan TR; Wishall KM; Kim SH; Grias I; Richard SD; Della Badia CR
J Minim Invasive Gynecol; 2015 Feb; 22(2):163-76. PubMed ID: 25218993
[TBL] [Abstract][Full Text] [Related]
18. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma.
Zurawin RK; Fischer JH; Amir L
J Minim Invasive Gynecol; 2010; 17(2):214-21. PubMed ID: 20226411
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Tissue Morcellation During Surgery for Uterine Sarcoma at a Canadian Academic Centre.
Chen I; Hopkins L; Firth B; Boucher J; Singh SS
J Obstet Gynaecol Can; 2015 May; 37(5):421-425. PubMed ID: 26168102
[TBL] [Abstract][Full Text] [Related]
20. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
